A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

This study has been terminated.

(A decision was made to discontinue the study due to a change in the strategic direction of the company.)

Sponsor:

Information provided by:

Janssen Pharmaceutical K.K.

ClinicalTrials.gov Identifier:

NCT00287742

First received: February 3, 2006

Last updated: May 20, 2011

Last verified: November 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	March 2003
Estimated Primary Completion Date:	No date given